𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quantitation of protein kinase C by immunoblot—expression in different cell lines and response to phorbol esters

✍ Scribed by S. Stabel; A. Rodriguez-Pena; S. Young; E. Rozengurt; P. J. Parker


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
850 KB
Volume
130
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Antisera have been raised against human protein kinase C and also against a synthetic peptide based on the squence of the bovine brain enzyme (LLNQEE-CEYYNVPIPE). These antibodies react with protein kinase C from a number of species (human, murine, rat, rabbit, bovine), indicating substantial conservation of epitopes. These antisera have been used to quantitate directly protein kinase C by immunoblot analysis. We show here that there is a strict correlation between the levels of immunoreactive polypeptide and extractable calcium-and phospholipid-dependent kinase activity for various cell lines. Treatment of rnurine, rat, and human cells with phorbol dibutyrate was found to deplete levels of immunoreactive protein kinase C severely. A detailed study of the time course of this depletion in Swiss 3T3 cells shows that it follows precisely the loss of extractable activity. On exposure to 400 nM phorbol 12,13-dibutyrate protein kinase C was essentially undetectable by 40 hours; the half-life of this down-regulation was 6.7 hours. This data thus demonstrate that the loss of immunoreactive protein kinase C and of extractable calcium-and phospholipid-dependent kinase activity precisely parallels the phorbol ester induced down-regulation of binding and responsiveness in Swiss 3T3 cells.

Protein kinase C is a calcium-and phospholipid-depen-Associated with this cellular desensitization, down-regdent kinase that is implicated in a variety of cellular ulation of phorbol ester binding has been documented in responses including long-term cell growth and tumour several cell types (Solanki et al., 1981; Collins and Rozpromotion (reviewed in Nishizuka, 1984a,b). Physiologi-engurt, 1982b;Phillips and Jaken, 1983; Collins and cally protein kinase C appears to be regulated by di-Rozengurt, 1984). The relationship between the phorbol acylglycerol, which is generated by phospholipid turn-ester receptor and protein kinase C has prompted invesover and activates the enzyme at submicromolar cal-tigations into the nature of this down-regulation with cium concentrations (see Berridge and Irvine, 1984; respect to protein kinase C. It has been shown that Nishizuka, 1986).

down-regulated cells show little or no measurable pro-The ability of diacylglycerols to activate protein ki-tein kinase C activity (Rodriguez-Pena and Rozengurt, nase C in vitro can be mimicked by biologically active 1984; Blackshear et al., 1985;Ballester and Rosen, 1985); phorbol esters (Castagna et al., 1982). These tumour furthermore there is evidence that the actual concentrapromoters and a number of structurally related and tion of protein kinase C polypeptide is severely diminunrelated promoters (Miyake et al., 1984; Fujiki et al., ished in down-regulated cells (Blackshear et al., 1985; 1984) can activate protein kinase C in vitro at concentra-Ballester and Rosen, 1985). It is not clear, however, tions comparable with those used to elicit biological whether the time course for the acquirement of cellular responses; this suggests that these tumour promoters refractoriness, reduction of phorbol ester binding, and may function through direct activation of protein kinase measurable protein kinase C (Rodriguez-Pena and Roz-C. Indeed, there is much evidence to suggest that the engurt, 1984) occur in parallel with the loss of cellular high affinity binding site for these promoters is polypeptide.


📜 SIMILAR VOLUMES


Protein kinase C activation and down-reg
✍ Jari E. Heikkilä; Göran Åkerlind; Karl E. O. Åkerman 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 933 KB

The role of protein kinase C activation in changes in muscarinic receptor functions and in the appearance of biochemical properties characteristic of neuronal cells was studied in SH-SY5Y human neuroblastoma cells induced to differentiate with the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (

Modulation by staurosporine of phorbol-e
✍ Tracey D. Bradshaw; Andreas Gescher; George R. Pettit 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 711 KB

I 2-0-tetradecanoylphorbol-I 3-acetate (TPA) and bryostatin I are activators of protein kinase C (PKC). TPA is a potent inhibitor of the growth of A549 cells, while bryostatin I exerts a weak antiproliferative effect upon this cell line. We tested the hypothesis that the PKC inhibitor staurosporine

Bile acids, non-phorbol-ester-type tumor
✍ X. P. Huang; X. T. Fan; J. F. Desjeux; M. Castagna 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 846 KB

Protein kinase C (PKC) is the target for a number of tumor promoters. The mechanism underlying the promoting effects of bile acids in colorectal cancer is not understood. We report that sodium deoxycholate (DOC) triggered activation of PKC in physiological conditions. The biphasic effects of DOC upo

Contrasting effects of the protein kinas
✍ Jacques Dornand; Monsif Bouaboula; Arnaud Dupuy D'Angeac; Jean Favero; David Shi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 1017 KB

EL 4-6.1 cells, variants of the murine EL4 thymoma cell line, can be activated by interleukin 1 (IL-I 1 or phorbol 12-myristdte-13-dcetate (PMA), or PMA + IL-I to secrete interleukin 2 (IL-2) and interleukin 4 (IL-4) and to express the IL-2 receptor (IL-2R). To compare the different activation pathw

Automated recognition system to classify
✍ Yuh-Show Tsai; I-Fang Chung; Jeremy C. Simpson; Mei-I Lee; Chia-Cheng Hsiung; Ta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 668 KB

## Abstract Systemic analysis of subcellular protein localization (location proteomics) provides clues for understanding gene functions and physiological condition of the cells. However, recognition of cell images of subcellular structures highly depends on experience and becomes the rate‐limiting

Doxorubicin induces expression of multid
✍ Chie Shinoda; Muneharu Maruyama; Takashi Fujishita; Junichi Dohkan; Hirofumi Oda 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 646 KB

Multidrug resistance (MDR) is a major impediment to successful chemotherapy for lung cancer. Overexpression of multidrug resistance-associated protein 1 (MRP1) appears to be involved in MDR development in lung cancer cells. A number of chemotherapeutic agents including doxorubicin (DOX) were reporte